60 Degrees Pharmaceuticals, Inc.

NasdaqCM:SXTP Stock Report

Market Cap: US$1.9m

60 Degrees Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:SXTP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Dec 24BuyUS$21,400Cheryl XuIndividual13,000US$1.85
09 Dec 24BuyUS$89,755Geoffrey DowIndividual73,951US$1.27
21 Nov 24BuyUS$6,367Geoffrey DowIndividual7,000US$0.92
27 Aug 24BuyUS$8,500Cheryl XuIndividual5,000US$1.70
31 Jan 24BuyUS$9,740Geoffrey DowIndividual2,164.5US$4.50
31 Jan 24BuyUS$75,000Cheryl XuIndividual16,666.66US$4.50

Insider Trading Volume

Insider Buying: SXTP insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SXTP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies53,7502.34%
Institutions70,4423.07%
Public Companies169,4927.38%
Hedge Funds196,2638.54%
Individual Insiders236,32710.3%
General Public1,571,19168.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 375.4%.

Top Shareholders

Top 22 shareholders own 49.24% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.6%
Florida State University Research Foundation Inc.
405,000US$334.3k0%no data
8.54%
Armistice Capital LLC
196,263US$162.0k0%no data
7.38%
Knight Therapeutics Inc.
169,492US$139.9k76.3%no data
6.54%
Geoffrey Dow
150,176US$124.0k136%no data
2.35%
Cheryl Xu
54,078US$44.6k31.7%no data
1.9%
Kentucky Technology, Inc
43,750US$36.1k0%no data
1.47%
Florida State University, Endowment Arm
33,750US$27.9k0%no data
0.64%
Tyrone Miller
14,744US$12.2k0%no data
0.6%
Douglas Loock
13,828US$11.4k0%no data
0.55%
Virtu Financial LLC, Asset Management Arm
12,678US$10.5k237%no data
0.44%
Citadel Advisors LLC
10,095US$8.3k0%no data
0.44%
Trevally, Llc
10,000US$8.3k0%no data
0.17%
National Bank Investments Inc.
4,000US$3.3k0%no data
0.14%
UBS Asset Management AG
3,311US$2.7k15.3%no data
0.14%
Geode Capital Management, LLC
3,166US$2.6k0%no data
0.064%
Tower Research Capital Europe Limited
1,473US$1.2k149%no data
0.06%
Safe Harbor Fiduciary, LLC
1,375US$1.1k0%no data
0.051%
Charles Allen
1,167US$963.30%no data
0.051%
Stephen Toovey
1,167US$963.30%no data
0.051%
Paul Field
1,167US$963.30%no data
0.026%
The Vanguard Group, Inc.
588US$485.30%no data
0.00026%
Bank of America Corporation, Asset Management Arm
6US$4.950%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/17 17:51
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

60 Degrees Pharmaceuticals, Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lucas WardAscendiant Capital Markets LLC
Edward WhiteH.C. Wainwright & Co.